TWIST2
Basic information
Region (hg38): 2:238848032-238910534
Links
Phenotypes
GenCC
Source:
- ablepharon macrostomia syndrome (Strong), mode of inheritance: AD
- Barber-Say syndrome (Strong), mode of inheritance: AD
- focal facial dermal dysplasia type III (Strong), mode of inheritance: AR
- ablepharon macrostomia syndrome (Supportive), mode of inheritance: AD
- Barber-Say syndrome (Supportive), mode of inheritance: AD
- focal facial dermal dysplasia type III (Supportive), mode of inheritance: AD
- ablepharon macrostomia syndrome (Definitive), mode of inheritance: AD
- focal facial dermal dysplasia type III (Strong), mode of inheritance: AR
Clinical Genomic Database
Source:
| Condition | Inheritance | Intervention Categories | Intervention/Rationale | Manifestation Categories | References |
|---|---|---|---|---|---|
| Ablepharon-macrostomia syndrome; Barber-Say syndrome; Focal facial dermal dysplasia 3, Setleis type | AD/AR | General | Genetic knowledge may be beneficial related to issues such as selection of optimal supportive care, informed medical decision-making, prognostic considerations, and avoidance of unnecessary testing | Craniofacial; Dermatologic; Musculoskeletal | 1867254; 2036354; 3631024; 4412216; 8368246; 8746822; 8818454; 11038439; 11807864; 12210295; 15103726; 16650233; 14069095; 20799330; 20830793; 20691403; 21801849; 21931173; 26119818 |
ClinVar
This is a list of variants' phenotypes submitted to
- not_provided (15 variants)
- Inborn_genetic_diseases (15 variants)
- Focal_facial_dermal_dysplasia_type_III (3 variants)
- Barber-Say_syndrome (3 variants)
- TWIST2-related_disorder (2 variants)
- Ablepharon_macrostomia_syndrome (1 variants)
- not_specified (1 variants)
Variants pathogenicity by type
Statistics on ClinVar variants can assist in determining whether a specific variant type in the TWIST2 gene is commonly pathogenic or not. These statistics are base on transcript: NM_001271893.4. Only rare variants are included in the table.
In the table, we include only reliable ClinVar variants with their consequences to MANE Select, Mane Plus Clinical transcripts, or transcripts with TSL equals 1. Click the count to view the source variants.
Warning: slight differences between displayed counts and the number of variants in ClinVar may occur, primarily due to (1) the application of a different transcript and/or consequence by our variant effect predictor or (2) differences in clinical significance: we classify Benign/Likely benign variants as Likely benign and Pathogenic/Likely pathogenic variants as Likely pathogenic.
| Effect | PathogenicP | Likely pathogenicLP | VUSVUS | Likely benignLB | BenignB | Sum |
|---|---|---|---|---|---|---|
| synonymous | 1 | 6 | 7 | |||
| missense | 3 | 21 | 24 | |||
| nonsense | 2 | 1 | 3 | |||
| start loss | 0 | |||||
| frameshift | 1 | 1 | ||||
| splice donor/acceptor (+/-2bp) | 0 | |||||
| Total | 6 | 0 | 23 | 6 | 0 |
Highest pathogenic variant AF is 0.0000056867007
GnomAD
Source:
| Gene | Type | Bio Type | Transcript | Coding Exons | Length |
|---|---|---|---|---|---|
| TWIST2 | protein_coding | protein_coding | ENST00000448943 | 1 | 39221 |
| pLI Probability LOF Intolerant | pRec Probability LOF Recessive | Individuals with no LOFs | Individuals with Homozygous LOFs | Individuals with Heterozygous LOFs | Defined | p |
|---|---|---|---|---|---|---|
| 0 | 0 | 0 | 0 | 0.00 |
| Z-Score | Observed | Expected | Observed/Expected | Mutation Rate | Total Possible in Transcript | |
|---|---|---|---|---|---|---|
| Missense | 2.13 | 33 | 89.9 | 0.367 | 0.00000412 | 1042 |
| Missense in Polyphen | 3 | 28.928 | 0.10371 | 354 | ||
| Synonymous | 1.88 | 25 | 40.2 | 0.622 | 0.00000191 | 311 |
| Loss of Function | 1.46 | 0 | 2.49 | 0.00 | 1.06e-7 | 33 |
LoF frequencies by population
| Ethnicity | Sum of pLOFs | p |
|---|---|---|
| African & African-American | 0.00 | 0.00 |
| Ashkenazi Jewish | 0.00 | 0.00 |
| East Asian | 0.00 | 0.00 |
| Finnish | 0.00 | 0.00 |
| European (Non-Finnish) | 0.00 | 0.00 |
| Middle Eastern | 0.00 | 0.00 |
| South Asian | 0.00 | 0.00 |
| Other | 0.00 | 0.00 |
dbNSFP
Source:
- Function
- FUNCTION: Binds to the E-box consensus sequence 5'-CANNTG-3' as a heterodimer and inhibits transcriptional activation by MYOD1, MYOG, MEF2A and MEF2C. Also represses expression of proinflammatory cytokines such as TNFA and IL1B. Involved in postnatal glycogen storage and energy metabolism (By similarity). Inhibits the premature or ectopic differentiation of preosteoblast cells during osteogenesis, possibly by changing the internal signal transduction response of osteoblasts to external growth factors. {ECO:0000250, ECO:0000269|PubMed:11062344}.;
- Disease
- DISEASE: Ablepharon-macrostomia syndrome (AMS) [MIM:200110]: A congenital ectodermal dysplasia characterized by absent eyelids, macrostomia, microtia, redundant skin, sparse hair, dysmorphic nose and ears, variable abnormalities of the nipples, genitalia, fingers, and hands, largely normal intellectual and motor development, and poor growth. {ECO:0000269|PubMed:26119818}. Note=The disease is caused by mutations affecting the gene represented in this entry.; DISEASE: Barber-Say syndrome (BBRSAY) [MIM:209885]: A rare ectodermal dysplasia characterized by ectropion, macrostomia, ear abnormalities, broad nasal bridge, bulbous nose, redundant skin, hypertrichosis, dental abnormalities, and variable other features. {ECO:0000269|PubMed:26119818}. Note=The disease is caused by mutations affecting the gene represented in this entry.;
- Pathway
- Proteoglycans in cancer - Homo sapiens (human);EMT transition in Colorectal Cancer;Transcriptional regulation by RUNX2;Gene expression (Transcription);Generic Transcription Pathway;RNA Polymerase II Transcription
(Consensus)
Essentials
- essential_gene_CRISPR
- N
- essential_gene_CRISPR2
- S
- essential_gene_gene_trap
- N
- gene_indispensability_pred
- E
- gene_indispensability_score
- 0.539
Gene Damage Prediction
| All | Recessive | Dominant | |
|---|---|---|---|
| Mendelian | Medium | Low | Medium |
| Primary Immunodeficiency | Medium | Low | Medium |
| Cancer | Medium | Medium | Medium |
Gene ontology
- Biological process
- multicellular organism development;cell differentiation;positive regulation of cell migration;negative regulation of apoptotic process;negative regulation of osteoblast differentiation;negative regulation of transcription, DNA-templated
- Cellular component
- nucleus;nucleolus;cytoplasm
- Molecular function
- DNA binding;protein binding;protein dimerization activity